Effect of Hepatic Impairment on the Pharmacokinetics of Mirdametinib
Effect of Hepatic Impairment on the Pharmacokinetics of Mirdametinib
Recruiting · NCT06997276 · Registry updated 2026-09-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effect of Hepatic Impairment on the Pharmacokinetics of Mirdametinib | Healthy; Hepatic Impairment | Recruiting | Phase 1 | 2026-09-21 | NCT06997276 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany | 6 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| American Research Corporation (Texas Liver Institute) | San Antonio | United States | 1 |
| Clinical Pharmacology of Miami | Miami | United States | 8 |
| Orlando Clinical Research Center | Orlando | United States | 14 |